あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/08/29 | 1,680 | 1,694 | 1,671 | 1,680 | +9 | +0.5% | 57,600 |
2023/08/28 | 1,661 | 1,680 | 1,661 | 1,671 | +8 | +0.5% | 38,400 |
2023/08/25 | 1,664 | 1,669 | 1,660 | 1,663 | -17 | -1% | 37,900 |
2023/08/24 | 1,669 | 1,690 | 1,667 | 1,680 | +11 | +0.7% | 49,400 |
2023/08/23 | 1,664 | 1,674 | 1,650 | 1,669 | +3 | +0.2% | 57,300 |
2023/08/22 | 1,655 | 1,667 | 1,646 | 1,666 | +19 | +1.2% | 48,800 |
2023/08/21 | 1,640 | 1,672 | 1,640 | 1,647 | +11 | +0.7% | 49,600 |
2023/08/18 | 1,641 | 1,652 | 1,623 | 1,636 | -23 | -1.4% | 62,200 |
2023/08/17 | 1,701 | 1,701 | 1,644 | 1,659 | -49 | -2.9% | 93,400 |
2023/08/16 | 1,680 | 1,727 | 1,666 | 1,708 | +28 | +1.7% | 108,200 |
2023/08/15 | 1,651 | 1,694 | 1,651 | 1,680 | +28 | +1.7% | 62,300 |
2023/08/14 | 1,695 | 1,700 | 1,647 | 1,652 | -42 | -2.5% | 99,700 |
2023/08/10 | 1,650 | 1,694 | 1,642 | 1,694 | +39 | +2.4% | 138,700 |
2023/08/09 | 1,640 | 1,665 | 1,640 | 1,655 | +15 | +0.9% | 104,200 |
2023/08/08 | 1,600 | 1,655 | 1,599 | 1,640 | +50 | +3.1% | 218,000 |
2023/08/07 | 1,583 | 1,604 | 1,553 | 1,590 | +9 | +0.6% | 109,200 |
2023/08/04 | 1,586 | 1,594 | 1,572 | 1,581 | -2 | -0.1% | 77,700 |
2023/08/03 | 1,591 | 1,591 | 1,570 | 1,583 | -8 | -0.5% | 88,800 |
2023/08/02 | 1,569 | 1,600 | 1,569 | 1,591 | +23 | +1.5% | 146,200 |
2023/08/01 | 1,562 | 1,568 | 1,545 | 1,568 | +8 | +0.5% | 67,500 |
2023/07/31 | 1,551 | 1,568 | 1,545 | 1,560 | +29 | +1.9% | 75,900 |
2023/07/28 | 1,520 | 1,531 | 1,510 | 1,531 | -4 | -0.3% | 91,000 |
2023/07/27 | 1,520 | 1,535 | 1,512 | 1,535 | +23 | +1.5% | 50,500 |
2023/07/26 | 1,520 | 1,520 | 1,505 | 1,512 | -4 | -0.3% | 52,100 |
2023/07/25 | 1,495 | 1,520 | 1,488 | 1,516 | +34 | +2.3% | 98,500 |
2023/07/24 | 1,495 | 1,495 | 1,471 | 1,482 | -2 | -0.1% | 63,500 |
2023/07/21 | 1,485 | 1,490 | 1,477 | 1,484 | +12 | +0.8% | 43,000 |
2023/07/20 | 1,471 | 1,489 | 1,466 | 1,472 | ±0 | ±0% | 55,300 |
2023/07/19 | 1,453 | 1,472 | 1,447 | 1,472 | +27 | +1.9% | 62,200 |
2023/07/18 | 1,445 | 1,457 | 1,442 | 1,445 | ±0 | ±0% | 35,800 |
2023/07/14 | 1,454 | 1,458 | 1,435 | 1,445 | -4 | -0.3% | 56,200 |
2023/07/13 | 1,435 | 1,453 | 1,435 | 1,449 | +27 | +1.9% | 59,200 |
2023/07/12 | 1,444 | 1,453 | 1,422 | 1,422 | -11 | -0.8% | 79,400 |
2023/07/11 | 1,435 | 1,442 | 1,422 | 1,433 | ±0 | ±0% | 108,600 |
2023/07/10 | 1,430 | 1,443 | 1,420 | 1,433 | +16 | +1.1% | 114,100 |
2023/07/07 | 1,413 | 1,427 | 1,403 | 1,417 | +3 | +0.2% | 99,800 |
2023/07/06 | 1,446 | 1,446 | 1,396 | 1,414 | -34 | -2.3% | 115,400 |
2023/07/05 | 1,424 | 1,452 | 1,418 | 1,448 | +29 | +2% | 92,900 |
2023/07/04 | 1,422 | 1,429 | 1,418 | 1,419 | -24 | -1.7% | 79,700 |
2023/07/03 | 1,450 | 1,457 | 1,439 | 1,443 | +2 | +0.1% | 58,200 |
2023/06/30 | 1,450 | 1,458 | 1,436 | 1,441 | -5 | -0.3% | 92,000 |
2023/06/29 | 1,450 | 1,459 | 1,440 | 1,446 | +4 | +0.3% | 117,400 |
2023/06/28 | 1,427 | 1,444 | 1,415 | 1,442 | +25 | +1.8% | 77,300 |
2023/06/27 | 1,455 | 1,455 | 1,400 | 1,417 | +17 | +1.2% | 117,800 |
2023/06/26 | 1,417 | 1,418 | 1,380 | 1,400 | -17 | -1.2% | 50,600 |
2023/06/23 | 1,435 | 1,439 | 1,407 | 1,417 | +10 | +0.7% | 112,600 |
2023/06/22 | 1,390 | 1,417 | 1,388 | 1,407 | +22 | +1.6% | 80,900 |
2023/06/21 | 1,380 | 1,400 | 1,375 | 1,385 | +17 | +1.2% | 191,900 |
2023/06/20 | 1,366 | 1,371 | 1,360 | 1,368 | +2 | +0.1% | 47,600 |
2023/06/19 | 1,362 | 1,370 | 1,353 | 1,366 | +23 | +1.7% | 89,900 |
401~
450
件表示中 / 991件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 237,600円 | +0.3% | +2.7% | 2.10% | 13.48倍 | 1.05倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
クオリプス | 805,000円 | +660.9% | - | 0.00% | - | 11.68倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
JCRファーマ | 44,700円 | -23.0% | - | 4.47% | - | 0.96倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム